Shelton Capital Management Bristol Myers Squibb CO Transaction History
Shelton Capital Management
- $3.99 Billion
- Q4 2024
A detailed history of Shelton Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shelton Capital Management holds 215,184 shares of BMY stock, worth $12.5 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
215,184
Previous 110,083
95.47%
Holding current value
$12.5 Million
Previous $5.7 Million
113.66%
% of portfolio
0.31%
Previous 0.15%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,752Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.59 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.54 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.51 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...